Search
for
Sort by
Research 571–600 of 1000+
- Ruxolitinib for the treatment of severe alopecia areata
- An investigation of vitamin D status in alopecia areata
- Race and Alopecia Areata amongst US Women
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Trichoscopic clues for diagnosis of alopecia areata and trichotillomania in Asians
- Narrowband ultraviolet B phototherapy for alopecia areata
- Five‐year experience in the treatment of alopecia areata with DPC
- Alopecia Areata in C3H/HeJ Mice Involves Leukocyte-mediated Root Sheath Disruption in Advance of Overt Hair Loss
- Turner's syndrome associated with psoriasis and alopecia areata
- A trial of 1% minoxidil used topically for severe alopecia areata
- Bimatoprost in the treatment of eyelash universalis alopecia areata
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse
- Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study
- Topical and intralesional therapies for alopecia areata
- Intralesional steroids for alopecia areata
- Human Leukocyte Antigen Class II Alleles Are Associated with Risk of Alopecia Areata
- Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
- Seventeen Cases of Alopecia Areata: Combination of SADBE Topical Immunotherapy with Other Therapies
- Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin
- Extensive alopecia areata: Results of treatment with 3% topical minoxidil
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
- Screening Guidelines for Thyroid Function in Children With Alopecia Areata
- Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern
- Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata
- Genetic association of <i>HLA‐DQB1</i> and <i>HLA‐DRB1</i> polymorphisms with alopecia areata in the Italian population
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Melanocytes: A possible autoimmune target in alopecia areata
- Alopecia areata during Interferon Alpha-2b/Ribavirin Therapy
- Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study